Boehringer Ingelheim Vetmedica Acquires Licensing Rights for Artilysin(R) Technology from Lysando AG

General Press Releases Wednesday August 13, 2014 14:56
REGENSBURG, Germany--(BUSINESS WIRE)--Aug. 12, 2014

Artilysin(R), a new and innovative technological approach in the fight against pathogenic and multi-resistant bacteria, developed by the research & development company Lysando, has arrived in the pharmaceutical industry. Boehringer Ingelheim Vetmedica has secured the licensing rights for the technology platform Artilysin(R). The company is hopeful to receive significant momentum and solutions from this new substance class for the problem of multi-resistant bacteria, which also is an increasing threat to the animal world.

Artilysin(R)s are proteins that, through a physical mechanism, selectively eliminate pathogenic, multi-resistant and persisting bacteria. By way of license, Boehringer Ingelheim Vetmedica is taking advantage of the possibilities presented by this technology. The scope of applications for Artilysin(R)s spans from human and animal medicine to the food industry and the area of hygiene. They work quickly and with their “friend or foe” identification very specifically and are completely biodegradable. Additionally, no resistances occurred during the expansive studies. Multi-resistant bacteria pose a significant threat to health due to the increasing ineffectiveness of antibiotics. The EU Commission estimates the annual number of deaths caused by multi-resistant bacteria at 25,000. Massive economic effects are linked to this fact.

The Boehringer Ingelheim Group is among the 20 leading pharmaceutical companies worldwide. Their focus areas include research & development, production and marketing of new medicines with significant therapeutic benefits for human and animal health. In 2013, Boehringer Ingelheim reported revenues of appr. 14.1 bn Euros.

Lysando itself is not a manufacturer of pharmaceutical products nor will it become one in the future; it only provides its new technology platform through licensing. "The acquisition of licensing rights for the Artilysin(R) technology by Boehringer Ingelheim Vetmedica is a decisive step in the acceptance of this new class of substances“, explains Markus Matuschka v. Greiffenclau, CEO of Lysando AG.

About Lysando:

Lysando AG is a technology leader in the area of antimicrobial proteins. Since its foundation in 2009, the privately financed research company has done research on artificial designer proteins with a team of scientists in the town of Regensburg. Artilysin(R)s represent a revolutionary breakthrough in the battle against multi-resistant bacteria. With this new technology platform, drugs and substances against pathogenic gram-negative and gram-positive bacteria can be specifically developed, both for antibiotic-resistant and persisting bacteria. With Artilysin(R)s, Lysando has created an effective alternative to antibiotics.

CONTACT:
Press Contact:
WBCO Public Relations & Business Communications GmbH
Frank Wollstein
Tel.: +49-(0)-69 / 133-880-36
Fax: +49-(0)-69 / 133-880-33
Email: f.woellstein@wbco.de

Latest Press Release

SPECA at 20: Strengthening the UN Special Programme for the Economies of Central Asia to deliver on the 2030 Agenda

Marking the 20th anniversary of the United Nations Special Programme for the Economies of Central Asia (SPECA), high-level participants from the seven landlocked participating countries - Azerbaijan, Afghanistan, Kazakhstan, Kyrgyzstan, Tajikistan,...

Photo Release: IMPACT organizes the first edition of Barista Champion at Terrazza restaurant

Mr. Loy Joon How (middle), General Manager of IMPACT Exhibition Management Co., Ltd., along with Mr. Jessada Kreesuradach, Manager of Group Restaurant, joined judges' panel for the first edition of Barista Champion competition organized by IMPACT...

DHL Express announces its 2019 price adjustments in Thailand

- Rate increase by an average of 4.9% for shipments weighing less than 70Kg, and 5% to 10% for shipments weighting more than 70Kg, effective January 1, 2019 September 21, 2018: DHL Express, the world's leading international express services provider,...

Photo Release: Thailand Prime Minister and his colleagues visit Digital Thailand Big Bang 2018

General Prayut Chan-o-cha, Prime Minister of Thailand and Miss Ajarin Pattanapanchai, Permanent Secretary of the Ministry of Digital Economy and Society, recently visit Seagate booth in the "Digital Thailand Big Bang 2018" under the "Thailand Big Data"...

FUN STAY AND FREE PLAY IN HUA HIN THIS OCTOBER AT CENTARA GRAND HUA HIN AND VANA NAVA

Pack your bags all moms and dads, and get ready for a fun and free school-holiday trip this October as Hua Hin's best-loved Centara Grand Beach Resort & Villas Hua Hin has recently launched a special "Stay & Play" package that features not only a...

Related Topics